Groundbreaking cancer drug enters first human trials
Disease control
Recruiting now
This is the first study in humans testing a new cancer drug called TGW101. Researchers will give the drug to 50 patients with advanced solid tumors to check if it's safe and to find the right dose. They'll also look for early signs that the drug might help shrink tumors in cancer…
Phase: PHASE1 • Sponsor: Tagworks Pharmaceuticals BV • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC